Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues
Premiums	$ 11,454	$ 11,039	$ 23,057	$ 22,064
Net investment income	321	278	611	555
TOTAL REVENUES	60,523	48,586	117,778	95,103
Benefits and expenses
Pharmacy and other service costs	44,492	33,442	85,923	64,901
Medical costs and other benefit expenses	9,515	9,034	18,955	18,080
Selling, general and administrative expenses	3,684	3,434	7,389	6,972
Amortization of acquired intangible assets	420	455	843	914
TOTAL BENEFITS AND EXPENSES	58,111	46,365	113,110	90,867
Income from operations	2,412	2,221	4,668	4,236
Interest expense and other	(375)	(363)	(697)	(721)
Loss on sale of businesses	0	0	(19)	0
Net realized investment (losses) gains	(48)	26	(1,884)	(30)
Income before income taxes	1,989	1,884	2,068	3,485
TOTAL INCOME TAXES	360	374	651	669
Net income	1,629	1,510	1,417	2,816
Less: Net income attributable to noncontrolling interests	81	50	146	89
SHAREHOLDERS’ NET INCOME	$ 1,548	$ 1,460	$ 1,271	$ 2,727
Shareholders' net income per share
Basic (in dollars per share)	$ 5.51	$ 4.96	$ 4.48	$ 9.24
Diluted (in dollars per share)	$ 5.45	$ 4.92	$ 4.43	$ 9.15
Pharmacy revenues
Revenues
Revenue from contract with customer	$ 45,101	$ 33,964	$ 87,137	$ 66,108
Fees and other revenues
Revenues
Revenue from contract with customer	$ 3,647	$ 3,305	$ 6,973	$ 6,376